US$ 26.52
retatrutide triple agonist gip glp-1 glucagon receptor Retatrutide: How the Compares to Tirzepatide Retatrutide 10mg — Triple Receptor
Description
This could make the drug less effective for managing blood sugar and weight

The lower $150$400 monthly prices are becoming more difficult to find

Avoid driving or using machinery until symptoms pass

It is not licensed by the MHRA, is unavailable through NHS or regulated private prescribing, and there is no peer-reviewed clinical evidence supporting its use for building skeletal muscle

Gove, D., A

Xie X et al